Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
2009-3-30
pubmed:abstractText
The Alzheimer's Disease Anti-inflammatory Prevention Trial (ADAPT) was designed to address whether non-steroidal anti-inflammatory drugs (NSAIDs) can prevent or delay the onset of Alzheimer's disease (AD).
pubmed:grant
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/19328435-11852171, http://linkedlifedata.com/resource/pubmed/commentcorrection/19328435-12355905, http://linkedlifedata.com/resource/pubmed/commentcorrection/19328435-12578437, http://linkedlifedata.com/resource/pubmed/commentcorrection/19328435-16828623, http://linkedlifedata.com/resource/pubmed/commentcorrection/19328435-16864813, http://linkedlifedata.com/resource/pubmed/commentcorrection/19328435-17111043, http://linkedlifedata.com/resource/pubmed/commentcorrection/19328435-17111045, http://linkedlifedata.com/resource/pubmed/commentcorrection/19328435-17192795, http://linkedlifedata.com/resource/pubmed/commentcorrection/19328435-17349430, http://linkedlifedata.com/resource/pubmed/commentcorrection/19328435-1833349, http://linkedlifedata.com/resource/pubmed/commentcorrection/19328435-2592527, http://linkedlifedata.com/resource/pubmed/commentcorrection/19328435-3331112, http://linkedlifedata.com/resource/pubmed/commentcorrection/19328435-3510570, http://linkedlifedata.com/resource/pubmed/commentcorrection/19328435-3611032, http://linkedlifedata.com/resource/pubmed/commentcorrection/19328435-497304, http://linkedlifedata.com/resource/pubmed/commentcorrection/19328435-7702448, http://linkedlifedata.com/resource/pubmed/commentcorrection/19328435-8290099, http://linkedlifedata.com/resource/pubmed/commentcorrection/19328435-8919494
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Mar
pubmed:issn
1552-5279
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
5
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
93-104
pubmed:dateRevised
2010-9-23
pubmed:meshHeading
pubmed-meshheading:19328435-Aged, pubmed-meshheading:19328435-Aged, 80 and over, pubmed-meshheading:19328435-Alzheimer Disease, pubmed-meshheading:19328435-Anti-Inflammatory Agents, Non-Steroidal, pubmed-meshheading:19328435-Brain, pubmed-meshheading:19328435-Cognition Disorders, pubmed-meshheading:19328435-Encephalitis, pubmed-meshheading:19328435-Female, pubmed-meshheading:19328435-Humans, pubmed-meshheading:19328435-Male, pubmed-meshheading:19328435-Naproxen, pubmed-meshheading:19328435-Neuropsychological Tests, pubmed-meshheading:19328435-Outcome Assessment (Health Care), pubmed-meshheading:19328435-Patient Selection, pubmed-meshheading:19328435-Placebos, pubmed-meshheading:19328435-Pyrazoles, pubmed-meshheading:19328435-Research Design, pubmed-meshheading:19328435-Sulfonamides, pubmed-meshheading:19328435-Time, pubmed-meshheading:19328435-Treatment Outcome
pubmed:year
2009
pubmed:articleTitle
Alzheimer's Disease Anti-inflammatory Prevention Trial: design, methods, and baseline results.
pubmed:publicationType
Journal Article, Randomized Controlled Trial, Multicenter Study, Research Support, N.I.H., Extramural